These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 14959916)
21. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. Marenzi G; Marana I; Lauri G; Assanelli E; Grazi M; Campodonico J; Trabattoni D; Fabbiocchi F; Montorsi P; Bartorelli AL N Engl J Med; 2003 Oct; 349(14):1333-40. PubMed ID: 14523141 [TBL] [Abstract][Full Text] [Related]
22. Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study. Huber W; Eckel F; Hennig M; Rosenbrock H; Wacker A; Saur D; Sennefelder A; Hennico R; Schenk C; Meining A; Schmelz R; Fritsch R; Weiss W; Hamar P; Heemann U; Schmid RM Radiology; 2006 Jun; 239(3):793-804. PubMed ID: 16714461 [TBL] [Abstract][Full Text] [Related]
23. Clinical inquiries. What interventions reduce the risk of contrast nephropathy for high-risk patients? Grossman PD; Burroughs M; Guthmann RA J Fam Pract; 2005 Apr; 54(4):365-7. PubMed ID: 15833230 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of N-acetylcysteine and hydration versus placebo and hydration in decreasing contrast-induced renal dysfunction in patients undergoing coronary angiography with or without concomitant percutaneous coronary intervention. Seyon RA; Jensen LA; Ferguson IA; Williams RG Heart Lung; 2007; 36(3):195-204. PubMed ID: 17509426 [TBL] [Abstract][Full Text] [Related]
25. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Maioli M; Toso A; Leoncini M; Gallopin M; Tedeschi D; Micheletti C; Bellandi F J Am Coll Cardiol; 2008 Aug; 52(8):599-604. PubMed ID: 18702961 [TBL] [Abstract][Full Text] [Related]
26. Prevention of contrast-induced renal dysfunction by N-acetylcysteine. Truth or myth? Billinger M; Hess OM; Meier B Eur Heart J; 2004 Feb; 25(3):188-9. PubMed ID: 14972417 [No Abstract] [Full Text] [Related]
27. Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis. Subramaniam RM; Suarez-Cuervo C; Wilson RF; Turban S; Zhang A; Sherrod C; Aboagye J; Eng J; Choi MJ; Hutfless S; Bass EB Ann Intern Med; 2016 Mar; 164(6):406-16. PubMed ID: 26830221 [TBL] [Abstract][Full Text] [Related]
28. Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature. Goldenberg I; Shechter M; Matetzky S; Jonas M; Adam M; Pres H; Elian D; Agranat O; Schwammenthal E; Guetta V Eur Heart J; 2004 Feb; 25(3):212-8. PubMed ID: 14972421 [TBL] [Abstract][Full Text] [Related]
29. Prevention of contrast-induced nephropathy by use of bicarbonate solution: preliminary results and literature review. Silva RG; Silva NG; Lucchesi F; Burdmann EA J Bras Nefrol; 2010; 32(3):292-302. PubMed ID: 21103694 [TBL] [Abstract][Full Text] [Related]
30. [Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents]. Hoshino A; Enomoto S; Kawahito H; Kurata H; Nakahara Y; Nakamura T J Cardiol; 2007 Aug; 50(2):119-26. PubMed ID: 17802695 [TBL] [Abstract][Full Text] [Related]
32. [Pathophysiology and prevention of contrast-induced acute renal failure]. Graziani G; Degnoni V; Oldani S; Buskermolen M; Brambilla G G Ital Nefrol; 2007; 24 Suppl 38():20-4. PubMed ID: 17922443 [TBL] [Abstract][Full Text] [Related]
33. Does the prophylactic use of N-acetylcysteine prevent contrast nephropathy in patients with renal insufficiency? Ma IW; Hladunewich M CMAJ; 2004 Apr; 170(8):1231. PubMed ID: 15078844 [No Abstract] [Full Text] [Related]
36. N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography. Schmidt P; Pang D; Nykamp D; Knowlton G; Jia H Ann Pharmacother; 2007 Jan; 41(1):46-50. PubMed ID: 17190844 [TBL] [Abstract][Full Text] [Related]
38. Prevention of contrast-induced nephropathy in patients undergoing emergent coronary procedures. Bouzas-Mosquera A; Vázquez-Rodríguez JM Am J Cardiol; 2008 Mar; 101(6):910. PubMed ID: 18328863 [No Abstract] [Full Text] [Related]
39. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). ACT Investigators Circulation; 2011 Sep; 124(11):1250-9. PubMed ID: 21859972 [TBL] [Abstract][Full Text] [Related]
40. A review of contemporary prevention strategies for radiocontrast nephropathy: a focus on fenoldopam and N-acetylcysteine. Lepor NE Rev Cardiovasc Med; 2003; 4 Suppl 1():S15-20. PubMed ID: 12556733 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]